Announcement

Collapse
No announcement yet.

Good quick read on oral vs. IM steroids and the effect on blood lipid profiles

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Good quick read on oral vs. IM steroids and the effect on blood lipid profiles

    PD Thompson, EM Cullinane, SP Sady, C Chenevert, AL Saritelli, MA Sady, and PN Herbert
    Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.
    JAMA, February 24, 1989; 261(8): 1165-8.

    Oral anabolic steroids produce striking reductions in serum concentrations of high-density lipoprotein (HDL) cholesterol. We hypothesized that this effect related to their route of administration and was unrelated to their androgenic potency. We administered oral stanozolol (6 mg/d) or supraphysiological doses of intramuscular testosterone enanthate (200 mg/wk) to 11 male weight lifters for six weeks in a crossover design. Stanozolol reduced HDL-cholesterol and the HDL2 subfraction by 33% and 71%, respectively. In contrast, testosterone decreased HDL-cholesterol concentration by only 9% and the decrease was in the HDL3 subfraction. Apolipoprotein A-I level decreased 40% during stanozolol but only 8% during testosterone treatment. The low-density lipoprotein cholesterol concentration increased 29% with stanozolol and decreased 16% with testosterone treatment. Stanozolol, moreover, increased postheparin hepatic triglyceride lipase activity by 123%, whereas the maximum change during testosterone therapy (+25%) was not significant. Weight gain was similar with both drugs, but testosterone was more effective in suppressing gonadotropic hormones. We conclude that the undesirable lipoprotein effects of 17-alpha-alkylated steroids given orally are different from those of parenteral testosterone and that the latter may be preferable in many clinical situations.

  • #2
    Also found it interesting that this study found that Winstrol DECREASED free T4 and T3.

    M Small, GH Beastall, CG Semple, RA Cowan, and CD Forbes
    Alteration of hormone levels in normal males given the anabolic steroid stanozolol.
    Clin Endocrinol (Oxf), July 1, 1984; 21(1): 49-55.

    Anabolic steroids have widespread metabolic effects but, to date, their proven clinical indications have been limited. Recently the 17 alpha-alkylated steroid, stanozolol, has been shown to be of value in a variety of commonly occurring vascular diseases. Its endocrine effects have received little attention and we have investigated the effect of administering a 14 d course of stanozolol (10 mg orally per day) on a variety of important hormonal pathways in nine healthy male subjects. Significant changes occurred as follows: a 55% reduction in serum testosterone levels was noted and was accompanied by reductions in 'derived' free testosterone, sex hormone binding globulin and LH levels; total T4 and T3 levels fell in association with a decrease in thyroxine binding globulin, but no alteration was detected in TSH or free T4 levels. Changes in vitamin D status, with falls in 25-hydroxycholecalciferol and vitamin D binding globulin were also observed. These effects were reversible on stopping treatment. Stanozolol therapy therefore leads to a number of hormonal changes, probably by an action at both pituitary and hepatic levels.

    Comment


    • #3

      Comment


      • #4
        good post.

        Comment

        Working...
        X